Contrasting dose-effects of multi-glycoside of Tripterygium wilfordii Hook. f. on glomerular inflammation and hepatic damage in two types of anti-thy1.1 glomerulonephritis

Journal of Pharmacological Sciences

Volumn 118, Issue 4, 2012, Pages 433-446

  Wan, Yi Gang ^a   Zhao, Qing ^b   Sun, Wei ^b   Zhang, Hui Lan ^c   Li, Min ^a   Wei, Qing Xue ^b   Wu, Wei ^a   Yue, Li Jun ^a   Wang, Qing ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Oriental Academy of Chinese Medicine   (Malaysia)

Author keywords

Anti Thy1.1 glomerulonephritis; Cytokine; Macrophage; Multi glycoside of tripterygium wilfordii Hook. F. (GTW); T lymphocyte

Indexed keywords

GAMMA INTERFERON; GLYCOSIDE; INTERLEUKIN 2;

ACUTE GLOMERULONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GENE EXPRESSION REGULATION; GLOMERULAR INFLAMMATION; GLOMERULOPATHY; IN VIVO STUDY; LIVER INJURY; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MESANGIUM CELL; NONHUMAN; PATHOLOGICAL ANATOMY; PROTEIN EXPRESSION; PROTEINURIA; RAT;

EID: 84867227822     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11157FP     Document Type: Article

References (40)

1. Brinker AM, Ma J, Lipsky PE, Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry. 2007;68:732-766.
2. Qian SZ, Xu Y, Zhang JW. Recent progress in research on Tripterygium: a male antifertility plant. Contraception. 1995;51:121-129.
3. Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.. Drugs R D. 2003;4:1-18.
4. Goldbach-Mansky R, Wilson M. Fleischmann R, Olsen N, Silverfield J, Kempf P, et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med. 2009;151:229.
5. Kupchan SM, Court WA, Dailey RG Jr, Gilmore CJ, Bryan RF. Ttiptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc. 1972;94:7194-7195.
6. Nakano K, Yoshida C, Furukawa W, Takaishi Y, Shishido K. Terpenoids in transformed root culture of Tripterygium wilfordii. Phytochemistry. 1998;49:1821-1824.
7. Li LS. [Clinical study of Tripterygium wilfordii Hook in treating glomerulonephritis]. Chin J Intern Med. 1981;20:216-220. (text in Chinese)
8. Liu ZH, Li SJ, Wu Y, Zuo K, Wang B, Zeng CH, et al. [Treatment of membranous nephropathy with Tripterygium wilfordii and steroid: a prospective randomized control trial]. J Nephrol Dialy Transplant. 2009;18:303-309. (text in Chinese)
9. Wan YG, Gu LB, Shimizu F. [Mechanism of protective effects of effective components in Ttipterygium wilfordii hook. f. on glomerulonephritis]. J Clin Exp Med. 2003;207:285-288. (text in Japanese)
10. Rong S, Hu WX, Liu ZH, Tang Z, Li LS. [A new regime of Tripterygium wilfordii hook. f. in treating primary mesangial proliferative glomerulonephritis]. J Nephrol Dialy Transplant. 1998;7:409-414. (text in Chinese)
11. Liu Q, Chen T, Chen G, Li N, Wang J, Ma P, et al. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem Biophys Res Commun. 2006;345:1122-1130.
12. Wan Y, Gu L, Suzuki K, Karasawa T, Fujioka Y, Han GD, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody. Nephron Exp Nephrol. 2005;99:e121-e129.
13. Xu G, Tu W, Jiang D, Xu C. Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis. Nephron Clin Pract. 2009;111:c223-c228.
14. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339:1448-1456.
15. Sudo H, Hirata M, Kanada H, Yorozu K, Tashiro Y, Serizawa K, et al. Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors. J Pharmacol Sci. 2009;111:53-59.
16. Hooke DH, Gee DC, Atkin RC. Leukocute analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int. 1987;31:964-972.
17. Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant. 2001;16 Suppl 5:3-7.
18. Remuzzi G, Zoja C, Perico N. Proinflammatory mediators of glomerular injury and mechanisms of activation of autoreactive T cells. Kidney Int. 1994;45 Suppl 44:S8-S16.
19. Kawachi H, Orikasa M, Matsui K, Iwanaga T, Toyabe S, Oite T, et al. Epitope-specific induction of mesangial lesion with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol. 1992;88:399-404.
20. Kawachi H, Iwanaga T, Toyabe S, Oite T, Shimizu F. Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3. Clin Exp Immunol. 1992;90:129-134.
21. Kawachi H, Oite T, Shimizu F. Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3. Clin Exp Immunol. 1993;92:342-346.
22. Minto AW, Erwig LP, Rees AJ. Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis. Am J Pathol. 2003;163:2033-2041.
23. Wan YG, Sun W, Shmizu F, Gu LB, Suziki K, Karasawa T, et al. [Suppressive effects of GTW treatment on mesangial lesions in experimental irreversible glomerulosclerosis]. China J Chin Mater Med. 2005;30:361-365. (text in Chinese)
24. Ikezumi Y, Kanno K, Karasawa T, Han GD, Ito Y, Koike H, et al. The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int. 2004;66:1036-1048.
25. Floege J, Burg M, Hugo C, Gordon KL, Goor HV, Reidy M, et al. Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol. 1998;9:792-801.
26. Krakower CA, Greenspon SA. Direct evidence for antigenicity of the glomeruli in the production of nephrotoxic serums. Arch Pathol. 1951;51:629-639.
27. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel multispecific competitor fragment quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods. 1994;177:23-28.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
29. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
30. Ikezumi Y, Kanno K, Koike H, Tomita M, Uchiyama M, Shimizu F, et al. FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy1.1 monoclonal antibody 1-22-3. Kidney Int. 2002;61:1339-1350.
31. Ikezumi Y, Kawachi H, Toyabe S, Uchiyama M, Shimizu F. An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis. Kidney Int. 2000;58:100-114.
32. Monga G, Mazzucco G, di Belgiojoso GB, Busnach G. The presence and possible role of monocyte infiltration in human chronic proliferative glomerulonephritides. Light microscopic, immunofluorescence, and histochemical correlations. Am J Pathol. 1979;94:271-284.
33. Nolasco FE, Cameron JS, Hartley B, Coelho A, Hildreth G, Reuben R. Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies. Kidney Int. 1987;31:1160-1166.
34. Kobayashi H, Orikasa M, Naito M, Kwasaki K, Oite T, Kawachi H, et al. Detailed analysis of phenotypes of macrophages infiltrating glomeruli in rat anti-Thy1 nephritis. Nephron. 1997;77:333-339.
35. Wan Y, Sun W, Zhang H, Yan Q, Chen P, Dou C, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates prolonged mesangial lesions in experimental progressive glomerulonephritis. Nephron Exp Nephrol. 2010;114:e7-e14.
36. Liu L, Jiang Z, Liu J, Huang X, Wang T, Liu J, et al. Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats. Toxicology. 2010;271:57-63.
37. Chen Y, Zhang XM, Han FM, Du P, Xia QS. Gene expression profile analyses of mice livers injured by Leigongteng. World J Gastroenterol. 2007;13:3619-3624.
38. Li J, Lu Y, Xiao C, Lu C, Niu X, He X, et al. Comparison of toxic reaction of Tripterygium wilfordii multiglycoside in normal and adjuvant arthritic rats. J Ethnopharmacol. 2011;135:270-277.
39. Naiki-Ito A, Asamoto M, Naiki T, Ogawa K, Takahashi S, Sato S, et al. Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol. 2010;38:280-286.
40. Jones DP, Lemasters JJ, Han D, Boelsterli UA, Kaplowitz N. Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv. 2010;10:98-111.